{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:47:13Z","timestamp":1793155633257,"version":"4.5.0"},"reference-count":102,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Tropica"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.actatropica.2019.105080","type":"journal-article","created":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T11:38:56Z","timestamp":1562672336000},"page":"105080","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["Nanocarriers for effective delivery of benznidazole and nifurtimox in the treatment of chagas disease: A review"],"prefix":"10.1016","volume":"198","author":[{"given":"Eva C.","family":"Arr\u00faa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia P.","family":"Seremeta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giselle R.","family":"Bedogni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora B.","family":"Okulik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio J.","family":"Salomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actatropica.2019.105080_bib0005","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1556-276X-8-102","article-title":"Liposome: classification, preparation, and applications","volume":"8","author":"Akbarzadeh","year":"2013","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/j.actatropica.2019.105080_bib0010","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jconrel.2017.06.003","article-title":"Nanosizing techniques for improving bioavailability of drugs","volume":"260","author":"Al-Kassas","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actatropica.2019.105080_bib0015","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.addr.2012.09.037","article-title":"Liposomal drug delivery systems: from concept to clinical applications","volume":"65","author":"Allen","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.actatropica.2019.105080_bib0020","doi-asserted-by":"crossref","first-page":"470","DOI":"10.2174\/1567201815666171207163504","article-title":"The role of nanoparticles in the inhibition of multidrug-resistant bacteria and biofilms","volume":"15","author":"AlMatar","year":"2017","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.actatropica.2019.105080_bib0025","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.addr.2007.04.007","article-title":"Solid lipid nanoparticles as a drug delivery system for peptides and proteins","volume":"59","author":"Almeida","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"9","key":"10.1016\/j.actatropica.2019.105080_bib0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005794","article-title":"Access to benznidazole for Chagas disease in the United States-Cautious optimism?","volume":"11","author":"Alpern","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2019.105080_bib0035","first-page":"540","article-title":"Chagas disease and transfusion medicine: a perspective from non-endemic countries","volume":"13","author":"Angheben","year":"2015","journal-title":"Blood Transfus."},{"key":"10.1016\/j.actatropica.2019.105080_bib0040","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejim.2017.05.001","article-title":"Chagas disease in Europe: a review for the internist in the globalized world","volume":"43","author":"Antinori","year":"2017","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.actatropica.2019.105080_bib0045","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1073\/pnas.0307312101","article-title":"A 9,000-year record of Chagas\u2019 disease","volume":"10","author":"Aufderheide","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.actatropica.2019.105080_bib0050","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.3389\/fmicb.2018.01441","article-title":"Nano-strategies to fight multidrug resistant Bacteria\u2014\u201cA battle of the titans\u201d","volume":"9","author":"Baptista","year":"2018","journal-title":"Front. Microbiol."},{"issue":"11","key":"10.1016\/j.actatropica.2019.105080_bib0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006809","article-title":"The economic value of identifying and treating Chagas disease patients earlier and the impact on Trypanosoma cruzi transmission","volume":"12","author":"Bartsch","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2019.105080_bib0060","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1056\/NEJMct1014204","article-title":"Antitrypanosomal therapy for chronic Chagas\u2019 disease","volume":"364","author":"Bern","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.actatropica.2019.105080_bib0065","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jconrel.2007.07.018","article-title":"The utility of cyclodextrins for enhancing oral bioavailability","volume":"123","author":"Carrier","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actatropica.2019.105080_bib0070","doi-asserted-by":"crossref","first-page":"18759","DOI":"10.3390\/molecules201018759","article-title":"Polymorph impact on the bioavailability and stability of poorly soluble drugs","volume":"20","author":"Censi","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.actatropica.2019.105080_bib0075","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/S0140-6736(06)68672-8","article-title":"Global framework on essential health R&D","volume":"367","author":"Chirac","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.actatropica.2019.105080_bib0080","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s40005-017-0370-4","article-title":"Nanomedicines: current status and future perspectives in aspect of drug delivery and pharmacokinetics","volume":"48","author":"Choi","year":"2018","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.actatropica.2019.105080_bib0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1381612824666171218125431","article-title":"Cyclodextrins as drug carriers in pharmaceutical technology: the state of the art","volume":"24","author":"Concei\u00e7\u00e3o","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.actatropica.2019.105080_bib0090","doi-asserted-by":"crossref","first-page":"807","DOI":"10.4269\/ajtmh.14-0562","article-title":"A national survey to determine prevalence of Trypanosoma cruzi infection among pregnant women in Ecuador","volume":"92","author":"Costales","year":"2015","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.actatropica.2019.105080_bib0095","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1208\/s12248-012-9339-4","article-title":"Challenges in development of nanoparticle-based therapeutics","volume":"14","author":"Desai","year":"2012","journal-title":"AAPS J."},{"key":"10.1016\/j.actatropica.2019.105080_bib0100","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jhealeco.2016.01.012","article-title":"Innovation in the pharmaceutical industry: new estimates of R&D costs","volume":"47","author":"DiMasi","year":"2016","journal-title":"J. Health Econ."},{"key":"10.1016\/j.actatropica.2019.105080_bib0105","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.drudis.2010.07.004","article-title":"Medicines discovery in the 21st century: the case for a stakeholder corporation","volume":"15","author":"Dixon","year":"2010","journal-title":"Drug Discov. Today"},{"issue":"1","key":"10.1016\/j.actatropica.2019.105080_bib0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006985","article-title":"A therapeutic preconceptional vaccine against Chagas disease: a novel indication that could reduce congenital transmission and accelerate vaccine development","volume":"13","author":"Dumonteil","year":"2019","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"1","key":"10.1016\/j.actatropica.2019.105080_bib0115","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s40249-018-0475-7","article-title":"Scoping review on vector-borne diseases in urban areas: transmission dynamics, vectorial capacity and co-infection","volume":"7","author":"Eder","year":"2018","journal-title":"Infect. Dis. Poverty"},{"key":"10.1016\/j.actatropica.2019.105080_bib0120","doi-asserted-by":"crossref","first-page":"e3312","DOI":"10.1371\/journal.pntd.0003312","article-title":"Trypanocide treatment of women infected with Trypanosoma cruzi and its effect on preventing congenital Chagas","volume":"8","author":"Fabbro","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2019.105080_bib0125","unstructured":"FDA (Food and Drug Administration). 2017. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/209570lbl.pdf."},{"key":"10.1016\/j.actatropica.2019.105080_bib0130","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.actatropica.2018.02.008","article-title":"Technological innovation strategies for the specific treatment of Chagas disease based on benznidazole","volume":"185","author":"Ferraz","year":"2018","journal-title":"Acta Trop."},{"key":"10.1016\/j.actatropica.2019.105080_bib0135","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ejps.2018.04.024","article-title":"Enhanced delivery of fixed-dose combination of synergistic antichagasic agents posaconazole- benznidazole based on amorphous solid dispersions","volume":"119","author":"Figueir\u00eado","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.actatropica.2019.105080_bib0140","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0035-9203(87)90020-4","article-title":"Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease","volume":"81","author":"Filardi","year":"1987","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.actatropica.2019.105080_bib0145","first-page":"73","article-title":"Nanomedicines: the magic bullets reaching their target? Eur","volume":"1","author":"Fl\u00fchmann","year":"2019","journal-title":"J. Pharm. Sci. Feb"},{"issue":"1","key":"10.1016\/j.actatropica.2019.105080_bib0150","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s40249-018-0473-9","article-title":"Effective surveillance systems for vector-borne diseases in urban settings and translation of the data into action: a scoping review","volume":"7","author":"Fournet","year":"2018","journal-title":"Infect. Dis. Poverty"},{"key":"10.1016\/j.actatropica.2019.105080_bib0155","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1377\/hlthaff.28.6.1760","article-title":"A business plan to help the\u2019 global South\u2019 in its fight against neglected diseases","volume":"28","author":"Frew","year":"2009","journal-title":"Health Aff."},{"key":"10.1016\/j.actatropica.2019.105080_bib0160","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1128\/AAC.49.4.1521-1528.2005","article-title":"Treatment with benznidazole during the chronic phase of experimental Chagas\u2019 disease decreases cardiac alterations","volume":"49","author":"Garcia","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2019.105080_bib0165","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3389\/fphar.2016.00351","article-title":"New approaches to overcome transport related drug resistance in trypanosomatid parasites","volume":"7","author":"Garcia-Salcedo","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.actatropica.2019.105080_bib0170","doi-asserted-by":"crossref","first-page":"288","DOI":"10.4103\/1735-5362.235156","article-title":"Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages","volume":"13","author":"Ghasemiyeh","year":"2018","journal-title":"Res. Pharm. Sci."},{"key":"10.1016\/j.actatropica.2019.105080_bib0175","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.2042-7158.1998.tb03301.x","article-title":"Characterization and trypanocidal activity of nifurtimox-containing and empty nanoparticles of polyethylcyanoacrylates","volume":"50","author":"Gonz\u00e1lez-Martin","year":"1998","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.actatropica.2019.105080_bib0180","doi-asserted-by":"crossref","first-page":"4286","DOI":"10.1128\/AAC.48.11.4286-4292.2004","article-title":"Activity of the new triazole derivative albaconazole against Trypanosoma (Schizotrypanum) cruzi in dog hosts","volume":"48","author":"Guedes","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2019.105080_bib0185","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1128\/AAC.05135-11","article-title":"Activation of benznidazole by trypanosomal type I nitroreductases results in glyoxal formation","volume":"56","author":"Hall","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2019.105080_bib0190","doi-asserted-by":"crossref","first-page":"13088","DOI":"10.1074\/jbc.M111.230847","article-title":"Nifurtimox activation by trypanosomal type I nitroreductases generates cytotoxic nitrile metabolites","volume":"286","author":"Hall","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.actatropica.2019.105080_bib0195","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.saa.2013.08.096","article-title":"Novel polymorphs of the anti-Trypanosoma cruzi drug benznidazole. Spectrochim","volume":"24","author":"Honorato","year":"2014","journal-title":"Acta A Mol. Biomol. Spectrosc"},{"key":"10.1016\/j.actatropica.2019.105080_bib0200","series-title":"Forgotten People, Forgotten Diseases: the Neglected Tropical Diseases and Their Impact on Global Health and Development","author":"Hotez","year":"2013"},{"issue":"12","key":"10.1016\/j.actatropica.2019.105080_bib0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005896","article-title":"Ten failings in global neglected tropical diseases control","volume":"11","author":"Hotez","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2019.105080_bib0210","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/S0140-6736(09)60233-6","article-title":"Rescuing the bottom billion through control of neglected tropical diseases","volume":"373","author":"Hotez","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.actatropica.2019.105080_bib0215","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/1471-0528.12396","article-title":"Frequency of the congenital transmission of Trypanosoma cruzi: a systematic review and meta-analysis","volume":"121","author":"Howard","year":"2014","journal-title":"BJOG"},{"key":"10.1016\/j.actatropica.2019.105080_bib0220","doi-asserted-by":"crossref","first-page":"790","DOI":"10.3389\/fphar.2018.00790","article-title":"Current trends and challenges in the clinical translation of nanoparticulate nanomedicines: pathways for translational development and commercialization","volume":"9","author":"Hua","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.actatropica.2019.105080_bib0225","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ijpharm.2009.04.026","article-title":"Lipid nanocapsules: a new platform for nanomedicine","volume":"379","author":"Huynh","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.actatropica.2019.105080_bib0230","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.actatropica.2017.02.019","article-title":"Nanopharmaceuticals as a solution to neglected diseases: Is it possible?","volume":"170","author":"Islan","year":"2017","journal-title":"Acta Trop."},{"issue":"10","key":"10.1016\/j.actatropica.2019.105080_bib0235","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1086\/656917","article-title":"Tolerance and safety of nifurtimox in patients with chronic Chagas disease","volume":"51","author":"Jackson","year":"2010","journal-title":"Clin. Infect. Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.actatropica.2019.105080_bib0240","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1590\/S0074-02762007005000106","article-title":"An overview of Chagas disease treatment","volume":"102","author":"Jannin","year":"2007","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.actatropica.2019.105080_bib0245","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1021\/mp034006h","article-title":"Molecular properties of WHO essential drugs and provisional Biopharmaceutical Classification","volume":"1","author":"Kasim","year":"2004","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.actatropica.2019.105080_bib0250","doi-asserted-by":"crossref","first-page":"e2562","DOI":"10.1371\/journal.pntd.0002562","article-title":"Elimination and eradication of neglected tropical diseases with mass drug administrations: a survey of experts","volume":"7","author":"Keenan","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2019.105080_bib0255","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2217\/nnm.14.41","article-title":"A vision for cyclodextrin nanoparticles in drug delivery systems and pharmaceutical applications","volume":"9","author":"Lakkakula","year":"2014","journal-title":"Nanomedicine"},{"key":"10.1016\/j.actatropica.2019.105080_bib0260","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S1473-3099(13)70002-1","article-title":"Global economic burden of Chagas disease: a computational simulation model","volume":"13","author":"Lee","year":"2013","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.actatropica.2019.105080_bib0265","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ijbiomac.2013.10.007","article-title":"Effects of benznidazole:cyclodextrin complexes on the drug bioavailability upon oral administration to rats","volume":"62","author":"Leonardi","year":"2013","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.actatropica.2019.105080_bib0270","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1002\/jps.22436","article-title":"The use of solid dispersion systems in hydrophilic carriers to increase benznidazole solubility","volume":"100","author":"Lima","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.actatropica.2019.105080_bib0275","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10847-011-0077-5","article-title":"Study of benznidazole-cyclodextrin inclusion complexes, cytotoxicity and trypanocidal activity","volume":"73","author":"Lyra","year":"2012","journal-title":"J. Incl. Phenom. Macrocycl. Chem."},{"issue":"Suppl 1","key":"10.1016\/j.actatropica.2019.105080_bib0280","doi-asserted-by":"crossref","first-page":"S177","DOI":"10.1016\/j.actatropica.2011.02.017","article-title":"Neglected tropical disease (NTD) control in health systems: the interface between programmes and general health services","volume":"120","author":"Marchal","year":"2011","journal-title":"Acta Trop."},{"key":"10.1016\/j.actatropica.2019.105080_bib0285","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1590\/S0100-40422010000800018","article-title":"Caracteriza\u00e7\u00e3o f\u00edsico-qu\u00edmica do f\u00e1rmaco antichag\u00e1sico benznidazol","volume":"33","author":"Maximiano","year":"2010","journal-title":"Quim. Nova"},{"key":"10.1016\/j.actatropica.2019.105080_bib0290","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s10973-011-1371-6","volume":"106","author":"Maximiano","year":"2011","journal-title":"J. Therm. Anal. Calorim."},{"key":"10.1016\/j.actatropica.2019.105080_bib0295","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0928-0987(02)00251-8","article-title":"Nanosizing: a formulation approach for poorly-water-soluble compounds","volume":"18","author":"Merisko-Liversidge","year":"2003","journal-title":"Eur. J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.actatropica.2019.105080_bib0300","article-title":"Solid lipid nanoparticles: emerging colloidal nano drug delivery systems","volume":"10","author":"Mishra","year":"2018","journal-title":"Pharmaceuticsm"},{"key":"10.1016\/j.actatropica.2019.105080_bib0305","doi-asserted-by":"crossref","first-page":"e336","DOI":"10.1371\/journal.pmed.0020336","article-title":"\u201cRapid-impact interventions\u201d: how a policy of integrated control for Africa\u2019s neglected tropical diseases cold benefit the poor","volume":"2","author":"Molyneux","year":"2005","journal-title":"PLoS Med."},{"key":"10.1016\/j.actatropica.2019.105080_bib0310","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0378-5173(02)00453-2","article-title":"Development and in vitro characterisation of a benznidazole liposomal formulation","volume":"249","author":"Morilla","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.actatropica.2019.105080_bib0315","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ijpharm.2004.03.025","article-title":"Intravenous liposomal benznidazole as trypanocidal agent: increasing drug delivery to liver is not enough","volume":"278","author":"Morilla","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.actatropica.2019.105080_bib0320","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00118-6","article-title":"Nanosuspensions as particulate drug formulations in therapy: rationale for development and what we can expect for the future","volume":"471","author":"M\u00fcller","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.actatropica.2019.105080_bib0325","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0166-6851(98)00037-1","article-title":"Molecular characterization of susceptible and naturally resistant strains of Trypanosoma cruzi to benznidazole and nifurtimox","volume":"93","author":"Murta","year":"1998","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.actatropica.2019.105080_bib0330","first-page":"2539","article-title":"Nanomedicine for drug targeting: strategies beyond the enhanced permeability and retention effect","volume":"9","author":"Nehoff","year":"2014","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.actatropica.2019.105080_bib0335","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.micromeso.2018.06.035","article-title":"Chitosan grafted into mesoporous silica nanoparticles as benznidazol carrier for Chagas diseases treatment","volume":"272","author":"Nhavene","year":"2018","journal-title":"Microporous Mesoporous Mater."},{"key":"10.1016\/j.actatropica.2019.105080_bib0340","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1039\/C2CS35265F","article-title":"Design, functionalization strategies and biomedical applications of targeted biodegradable\/biocompatible polymer-based nanocarriers for drug delivery","volume":"42","author":"Nicolas","year":"2013","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.actatropica.2019.105080_bib0345","series-title":"Drug Delivery Nanoparticles Formulation and Characterization","author":"Pathak","year":"2016"},{"key":"10.1016\/j.actatropica.2019.105080_bib0350","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0140-6736(17)31612-4","article-title":"Chagas disease","volume":"391","author":"P\u00e9rez-Molina","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.actatropica.2019.105080_bib0355","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/S0140-6736(10)60061-X","article-title":"Chagas\u2019 disease","volume":"375","author":"Rassi","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.actatropica.2019.105080_bib0360","doi-asserted-by":"crossref","first-page":"b1283","DOI":"10.1136\/bmj.b1283","article-title":"Eliminating Chagas disease: challenges and a roadmap","volume":"338","author":"Reithinger","year":"2009","journal-title":"BMJ"},{"issue":"12","key":"10.1016\/j.actatropica.2019.105080_bib0365","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006119","article-title":"Elucidating the impact of low doses of nano-formulated benznidazole in acute experimental Chagas disease","volume":"11","author":"Rial","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2019.105080_bib0370","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1590\/S0074-02762002000100001","article-title":"A critical review on Chagas disease chemotherapy","volume":"97","author":"Rodriques Coura","year":"2002","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.actatropica.2019.105080_bib0375","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.2147\/IJN.S33048","article-title":"Highly deformable and highly fluid vesicles as potential drug delivery systems: theoretical and practical considerations","volume":"8","author":"Romero","year":"2013","journal-title":"Int. J. Nanomed. Nanosurg."},{"key":"10.1016\/j.actatropica.2019.105080_bib0380","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.3109\/10837450.2011.644299","article-title":"Modulated dissolution rate from the inclusion complex of antichagasic benznidazole and cyclodextrin using hydrophilic polymer","volume":"18","author":"S\u00e1-Barreto","year":"2013","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.actatropica.2019.105080_bib0385","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.4269\/ajtmh.16-0761","article-title":"Experimental and clinical treatment of Chagas disease: a Review","volume":"97","author":"Sales Junior","year":"2017","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.actatropica.2019.105080_bib0390","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/jps.23010","article-title":"First century of Chagas disease: an overview on novel approaches to nifurtimox and benznidazole delivery systems","volume":"101","author":"Salomon","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.actatropica.2019.105080_bib0395","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4067\/S0716-97602002000100007","article-title":"Cytotoxicity and trypanocidal activity of nifurtimox encapsulated in ethylcyanoacrylate nanoparticles","volume":"35","author":"S\u00e1nchez","year":"2002","journal-title":"Biol. Res."},{"key":"10.1016\/j.actatropica.2019.105080_bib0400","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1111\/tmi.12980","article-title":"Development and in vitro\/in vivo evaluation of a novel benznidazole liquid dosage form using a quality-by-design approach","volume":"22","author":"Santos Souza","year":"2017","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.actatropica.2019.105080_bib0405","doi-asserted-by":"crossref","first-page":"388","DOI":"10.4269\/ajtmh.15-0889","article-title":"Promising efficacy of benznidazole nanoparticles in acute Trypanosoma Cruzi murine model: in-vitro and in-vivo studies","volume":"95","author":"Scalise","year":"2016","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"19","key":"10.1016\/j.actatropica.2019.105080_bib0410","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201704463","article-title":"Nanoparticle-cell interaction: a cell mechanics perspective","volume":"30","author":"Septiadi","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.actatropica.2019.105080_bib0415","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3389\/fphar.2015.00286","article-title":"Advances and challenges of liposome assisted drug delivery","volume":"6","author":"Sercombe","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.actatropica.2019.105080_bib0420","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.colsurfb.2019.01.039","article-title":"Development and characterization of benznidazole nano- and microparticles: a new tool for pediatric treatment of Chagas disease?","volume":"177","author":"Seremeta","year":"2019","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.actatropica.2019.105080_bib0425","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40005-013-0051-x","article-title":"Nanosuspensions: a new approach for organ and cellular targeting in infectious diseases","volume":"43","author":"Shegokar","year":"2013","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.actatropica.2019.105080_bib0430","doi-asserted-by":"crossref","first-page":"324","DOI":"10.2174\/156720108785915087","article-title":"Solid lipid nanoparticles and nanostructured lipid carriers--innovative generations of solid lipid carriers","volume":"5","author":"Shidhaye","year":"2008","journal-title":"Curr. Drug Deliv."},{"issue":"4","key":"10.1016\/j.actatropica.2019.105080_bib0435","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005507","article-title":"Unraveling Chagas disease transmission through the oral route: gateways to Trypanosoma cruzi infection and target tissues","volume":"11","author":"Silva-dos-Santos","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2019.105080_bib0440","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijpharm.2013.01.019","article-title":"Bottom-up approaches for preparing drug nanocrystals: formulations and factors affecting particle size","volume":"453","author":"Sinha","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.actatropica.2019.105080_bib0445","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.carbpol.2012.02.042","article-title":"Benznidazole drug delivery by binary and multicomponent inclusion complexes using cyclodextrins and polymers","volume":"89","author":"Soares-Sobrinho","year":"2012","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.actatropica.2019.105080_bib0450","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1208\/s12249-015-0344-7","article-title":"Improved aqueous solubility and antihypercholesterolemic activity of ezetimibe on formulating with hydroxypropyl-\u03b2-cyclodextrin and hydrophilic auxiliary substances","volume":"17","author":"Srivalli","year":"2016","journal-title":"AAPS PharmSciTech"},{"issue":"5","key":"10.1016\/j.actatropica.2019.105080_bib0455","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006365","article-title":"Impact of vector biology research on old and emerging neglected tropical diseases","volume":"12","author":"Valenzuela","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2019.105080_bib0460","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1590\/S0074-02762001000700021","article-title":"Variation in susceptibility to benznidazole in isolates derived from trypanosoma cruzi parental strains","volume":"96","author":"Veloso","year":"2001","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.actatropica.2019.105080_bib0465","doi-asserted-by":"crossref","first-page":"e2410","DOI":"10.1371\/journal.pntd.0002410","article-title":"Socio-cultural aspects of Chagas disease: a systematic review of qualitative research","volume":"7","author":"Ventura-Garcia","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"1","key":"10.1016\/j.actatropica.2019.105080_bib0470","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006240","article-title":"Trypanosoma cruzi vaccine candidate antigens Tc24 and TSA-1 recall memory immune response associated with HLA-A and -B supertypes in Chagasic chronic patients from Mexico","volume":"12","author":"Villanueva-Lizama","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2019.105080_bib0475","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.4269\/ajtmh.17-0044","article-title":"Benznidazole nanoformulates: a chance to improve therapeutics for Chagas disease","volume":"97","author":"Vinuesa","year":"2017","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.actatropica.2019.105080_bib0480","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1586\/14787210.7.2.157","article-title":"Side effects of benznidazole as treatment in chronic Chagas\u2019 disease: fears and realities","volume":"7","author":"Viotti","year":"2009","journal-title":"Expert Rev. Anti. Ther."},{"issue":"1","key":"10.1016\/j.actatropica.2019.105080_bib0485","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s40249-018-0444-1","article-title":"Innovation in neglected tropical disease drug discovery and development","volume":"7","author":"Weng","year":"2018","journal-title":"Infect. Dis. Poverty"},{"key":"10.1016\/j.actatropica.2019.105080_bib0490","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399409001252","article-title":"Trypanocidal drugs: mechanisms, resistance and new targets","volume":"11","author":"Wilkinson","year":"2009","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.actatropica.2019.105080_bib0495","first-page":"33","article-title":"Chagas disease in Latin America: an epidemiological update based on 2010 estimates","volume":"90","author":"World Health Organization","year":"2015","journal-title":"Wkly. Epidemiol. Rec."},{"key":"10.1016\/j.actatropica.2019.105080_bib0500","series-title":"Report of the Tenth Meeting of the WHO Strategic and Technical Advisory Group for Neglected Tropical Diseases","author":"World Health Organization","year":"2017"},{"key":"10.1016\/j.actatropica.2019.105080_bib0505","series-title":"The International Pharmacopoeia","author":"World Health Organization","year":"2018"},{"key":"10.1016\/j.actatropica.2019.105080_bib0510","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0065-308X(05)61004-4","article-title":"Control of chagas disease","volume":"61","author":"Yamagata","year":"2006","journal-title":"Adv. Parasitol."}],"container-title":["Acta Tropica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X19305078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X19305078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:14:22Z","timestamp":1757549662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001706X19305078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":102,"alternative-id":["S0001706X19305078"],"URL":"https:\/\/doi.org\/10.1016\/j.actatropica.2019.105080","relation":{},"ISSN":["0001-706X"],"issn-type":[{"value":"0001-706X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanocarriers for effective delivery of benznidazole and nifurtimox in the treatment of chagas disease: A review","name":"articletitle","label":"Article Title"},{"value":"Acta Tropica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actatropica.2019.105080","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105080"}}